Results 151 to 160 of about 130,799 (313)

Hospital Pharmacist in the Emergency Department

Iberoamerican Journal of Medicine, 2020
Yared González-Pérez, Carlos Sáiz de Rozas Aparicio   +1 more
doaj   +1 more source

Clinical pharmacist-led interventions and their impact on outcomes in patients with bipolar I disorder: a systematic review and meta-analysis. [PDF]

Front Med (Lausanne)
Khobrani M, Alshahrani SM.
europepmc   +1 more source

The role and responsibilities of sports pharmacists in athlete health management [PDF]

Bakkiya selvan, M Sangeetha, Devanadhan RR   +2 more
openalex   +1 more source

In vitro properties of patient serum predict clinical outcome after high dose rate brachytherapy of hepatocellular carcinoma

Molecular Oncology, EarlyView.
Following high dose rate brachytherapy (HDR‐BT) for hepatocellular carcinoma (HCC), patients were classified as responders and nonresponders. Post‐therapy serum induced increased BrdU incorporation and Cyclin E expression of Huh7 and HepG2 cells in nonresponders, but decreased levels in responders.
Lukas Salvermoser, Jan Niklas Schäfer, Shraga Nahum Goldberg, Philipp Maximilian Kazmierczak, Moritz Nikolaus Gröper, Philipp Franz Linden, Elif Öcal, Tanja Burkard, Stefanie Corradini, Najib Ben Khaled, Moritz Wildgruber, Max Seidensticker, Jens Ricke, Matthias Stechele, Marianna Alunni‐Fabbroni   +14 more
wiley   +1 more source

The role of pharmacists in geriatric care: current evidence and practice. [PDF]

Aging Clin Exp Res
Harasani K, Duque S, Piotrowicz K, Lavrador M, Figueiredo IV, Castel-Branco MM, Gjonbrataj J, Kotsani M.   +7 more
europepmc   +1 more source

An Online Virtual-Patient Program to Teach Pharmacists and Pharmacy Students How to Provide Diabetes-Specific Medication Therapy Management [PDF]

, 2012
Jessica N. Battaglia, Mara Kieser, Ruth H. Bruskiewitz, Michael E. Pitterle, Joshua M. Thorpe   +4 more
openalex   +1 more source

Reporting interpersonal violence and abuse: What pharmacists need to know [PDF]

, 2020
Marie Barnard, Alexa Sinha, Wesley Sparkmon, Erin R. Holmes   +3 more
openalex   +1 more source

Inhibition of CDK9 enhances AML cell death induced by combined venetoclax and azacitidine

Molecular Oncology, EarlyView.
The CDK9 inhibitor AZD4573 downregulates c‐MYC and MCL‐1 to induce death of cytarabine (AraC)‐resistant AML cells. This enhances VEN + AZA‐induced cell death significantly more than any combination of two of the three drugs in AraC‐resistant AML cells.
Shuangshuang Wu, Jianlei Zhao, Aaban Asfar Azmi, Avanti Gupte, Jenna Thibodeau, Shuang Liu, Jinli Yang, Guan Wang, Holly Edwards, Lisa A. Polin, Juiwanna Kushner, Sijana H. Dzinic, Kathryn White, Julie Boerner, Maik Hüttemann, Jay Yang, Yue Wang, Jeffrey W. Taub, Yubin Ge   +18 more
wiley   +1 more source

Pharmacists Unite!

The Canadian Journal of Hospital Pharmacy, 2011
openaire   +3 more sources

A synthetic benzoxazine dimer derivative targets c‐Myc to inhibit colorectal cancer progression

Molecular Oncology, EarlyView.
Benzoxazine dimer derivatives bind to the bHLH‐LZ region of c‐Myc, disrupting c‐Myc/MAX complexes, which are evaluated from SAR analysis. This increases ubiquitination and reduces cellular c‐Myc. Impairing DNA repair mechanisms is shown through proteomic analysis.
Nicharat Sriratanasak, Bodee Nutho, Worawat Wattanathana, Narumon Phaonakrop, Bunnatut Panasawatwong, Katharina Erlenbach‐Wuensch, Sittiruk Roytrakul, Regine Schneider‐Stock, Pithi Chanvorachote   +8 more
wiley   +1 more source